4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-025194
Chief Business Officer sold 6,944 shares at $51.40 ($356,956)
- Chief Business Officer acquired 6,944 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parrish Jay · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-01 | Exercise or conversion : show line 1 in the form | +4,629 | $1.49 | $6,874 | 13,889 | D |
| 2021-04-01 | Exercise or conversion : show line 2 in the form | +2,315 | $1.58 | $3,646 | 16,204 | D |
| 2021-04-01 | Sale : show line 3 in the form | −6,944 | $51.40 | $356,956 | 9,260 | D |
| Open-market sales · 6,944 sh · avg $51.40 · $356,956 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-01 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −4,629 | 4,630 | D |
| 2021-04-01 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −2,315 | 37,037 | D |
Loading xslF345X03/doc4.xml…